Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of Phase 1 of this clinical research study is to test the safety and tolerability of
AMG 479 when given with trastuzumab.
The goal of Phase 2 of this clinical research study is to learn if the combination of AMG 479
and trastuzumab can help to control breast cancer.
AMG 479 is designed to block tumor cells from growing and spreading.
Trastuzumab is designed to prevent or slow down the growth of cancer cells by blocking
proteins inside the cancer cell.